FDA outlines postmarket surveillance plan ahead of public meetings

FDA outlines postmarket surveillance plan ahead of public meetings-massdevice.com:


Ahead of a 4-day public meeting blitz, the FDA released a preliminary proposal for strengthening medical device post-market surveillance.